Euclidean Capital LLC Buys Tenaya Therapeutics Inc, Surrozen Inc, Pinduoduo Inc, Sells PMV Pharmaceuticals Inc, Denali Therapeutics Inc,

• New Purchases: TNYA, SRZN,
• Added Positions: PDD,
• Reduced Positions: PMVP, NGM, ORIC, RAPT,
• Sold Out: DNLI, CNST, SNOW, NRIX, BEAM, VIR,

For the details of Euclidean Capital LLC's stock buys and sells, go to https://www.gurufocus.com/guru/euclidean+capital+llc/current-portfolio/portfolio

1. PMV Pharmaceuticals Inc (PMVP) - 2,769,813 shares, 40.12% of the total portfolio. Shares reduced by 29.14%
2. Alector Inc (ALEC) - 980,894 shares, 10.88% of the total portfolio.
3. RAPT Therapeutics Inc (RAPT) - 635,177 shares, 9.59% of the total portfolio. Shares reduced by 13.68%
4. Tenaya Therapeutics Inc (TNYA) - 915,705 shares, 9.19% of the total portfolio. New Position
5. Foghorn Therapeutics Inc (FHTX) - 1,261,261 shares, 8.54% of the total portfolio.

Euclidean Capital LLC initiated holding in Tenaya Therapeutics Inc. The purchase prices were between $15.35 and $26.66, with an estimated average price of $21.56. The stock is now traded at around $22.900000. The impact to a portfolio due to this purchase was 9.19%. The holding were 915,705 shares as of 2021-09-30.

Euclidean Capital LLC initiated holding in Surrozen Inc. The purchase prices were between $6.98 and $12.03, with an estimated average price of $8.91. The stock is now traded at around $9.250000. The impact to a portfolio due to this purchase was 2.76%. The holding were 802,965 shares as of 2021-09-30.

Euclidean Capital LLC added to a holding in Pinduoduo Inc by 25.05%. The purchase prices were between $74.69 and $121.84, with an estimated average price of $97.66. The stock is now traded at around $93.900000. The impact to a portfolio due to this purchase was 0.11%. The holding were 12,262 shares as of 2021-09-30.

Euclidean Capital LLC sold out a holding in Denali Therapeutics Inc. The sale prices were between $48.48 and $78.23, with an estimated average price of $56.65.

Euclidean Capital LLC sold out a holding in . The sale prices were between $33.9 and $33.99, with an estimated average price of $33.95.

Euclidean Capital LLC sold out a holding in Snowflake Inc. The sale prices were between $236.75 and $324.08, with an estimated average price of $284.09.

Euclidean Capital LLC sold out a holding in Nurix Therapeutics Inc. The sale prices were between $22.71 and $36.69, with an estimated average price of $30.82.

Euclidean Capital LLC sold out a holding in Beam Therapeutics Inc. The sale prices were between $84.37 and $133.6, with an estimated average price of $101.1.

Euclidean Capital LLC sold out a holding in Vir Biotechnology Inc. The sale prices were between $34.9 and $54.54, with an estimated average price of $43.35.